Related references
Note: Only part of the references are listed.Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer
Tian He et al.
MOLECULAR ONCOLOGY (2021)
miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway
Jinjin Duan et al.
BIOSCIENCE REPORTS (2021)
Mutational Landscape and Evolutionary Pattern of Liver and Brain Metastasis in Lung Adenocarcinoma
Tao Jiang et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures
Alex Friedlaender et al.
CANCER TREATMENT REVIEWS (2020)
Runx1t1 promotes the neuronal differentiation in rat hippocampus
Linqing Zou et al.
STEM CELL RESEARCH & THERAPY (2020)
TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer
Fang Zhou et al.
MEDICAL SCIENCE MONITOR (2020)
Durvalumab (D) compared to maintenance chemotherapy (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the randomized SAFIR02 LUNG-IMMUNO trial
F. Barlesi et al.
ANNALS OF ONCOLOGY (2020)
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic
N. Vilarino et al.
CANCER TREATMENT REVIEWS (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study
Pascale Tomasini et al.
Oncotarget (2020)
BCL-2 family isoforms in apoptosis and cancer
Chloe F. A. Warren et al.
CELL DEATH & DISEASE (2019)
PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway
Yuxin Bai et al.
EBIOMEDICINE (2019)
WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling
Shaojie Jiang et al.
CELL COMMUNICATION AND SIGNALING (2019)
Immunotherapy of brain metastases: breaking a dogma
Anna Maria Di Giacomo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
Hauke Stamm et al.
ONCOIMMUNOLOGY (2019)
RAD52 Functions in Homologous Recombination and Its Importance on Genomic Integrity Maintenance and Cancer Therapy
Augusto Nogueira et al.
CANCERS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Effect of pemetrexed on brain metastases from nonsmall cell lung cancer with wild-type and unknown EGFR status
Xiaoqing Yu et al.
MEDICINE (2019)
Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer
Xiheng Hu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases
Pascale Tomasini et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Tale of the Good and the Bad Cdk5: Remodeling of the Actin Cytoskeleton in the Brain
Kavita Shah et al.
MOLECULAR NEUROBIOLOGY (2018)
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
Eskil Eskilsson et al.
NEURO-ONCOLOGY (2018)
Elevated transgelin/TNS1 expression is a potential biomarker in human colorectal
Huimin Zhou et al.
ONCOTARGET (2018)
KRAS-Mutant non-small cell lung cancer: From biology to therapy
Irene Ferrer et al.
LUNG CANCER (2018)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas
Longtao Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK plus ) non-small-cell lung cancer: CNS efficacy results from the ALEX study
S. Gadgeel et al.
ANNALS OF ONCOLOGY (2018)
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
Thanyanan Reungwetwattana et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CDK5 Functions as a Tumor Promoter in Human Lung Cancer
Jie Zeng et al.
JOURNAL OF CANCER (2018)
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Daniel N. Cagney et al.
NEURO-ONCOLOGY (2017)
Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W. Sperduto et al.
JAMA ONCOLOGY (2017)
Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain
Mayur M. Patel et al.
CNS DRUGS (2017)
The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer
Solange Peters et al.
CANCER TREATMENT REVIEWS (2016)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2016)
Blood-brain Barrier Remodeling during Brain Metastasis Formation
Jagoda K. Wrobel et al.
MOLECULAR MEDICINE (2016)
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Joshua D. Campbell et al.
NATURE GENETICS (2016)
Aberrations in the Iron Regulatory Gene Signature Are Associated with Decreased Survival in Diffuse Infiltrating Gliomas
Cody Weston et al.
PLOS ONE (2016)
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
Pascale Tomasini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study
Benjamin Besse et al.
CLINICAL CANCER RESEARCH (2015)
Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study
Denis Moro-Sibilot et al.
LUNG CANCER (2015)
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers
Deepa Rangachari et al.
LUNG CANCER (2015)
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K. Brastianos et al.
CANCER DISCOVERY (2015)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
AGAP3 and Arf6 Regulate Trafficking of AMPA Receptors and Synaptic Plasticity
Yuko Oku et al.
JOURNAL OF NEUROSCIENCE (2013)
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Nathan T. Ihle et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Suppression of Glioma Progression by Egln3
Vicki A. Sciorra et al.
PLOS ONE (2012)
RUNX1T1: A Novel Predictor of Liver Metastasis in Primary Pancreatic Endocrine Neoplasms
Aejaz Nasir et al.
PANCREAS (2011)
Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells
S. R. Chirasani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Share Paper
